Graduate Institute of Clinical Medicine

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 35%
3. Meta-Analysis 34%
4. Stroke 31%
5. Cohort Studies 29%
6. Population 28%
7. Confidence Intervals 26%
8. Therapeutics 24%
9. Chronic Renal Insufficiency 22%
10. Apoptosis 21%
11. Randomized Controlled Trials 19%
12. Systematic Reviews 19%
13. Atrial Fibrillation 19%
14. Pulmonary Veins 18%
15. Odds Ratio 18%
16. Arsenic 18%
17. Neoplasm Metastasis 18%
18. Genes 18%
19. Breast Neoplasms 18%
20. Hepatocellular Carcinoma 17%
21. Kidney 17%
22. Mortality 16%
23. Colorectal Neoplasms 16%
24. Bipolar Disorder 15%
25. Renal Dialysis 15%
26. Proteins 15%
27. Down-Regulation 14%
28. Biomarkers 14%
29. Cardiac Myocytes 13%
30. Lung 13%
31. Incidence 13%
32. Reactive Oxygen Species 12%
33. Databases 12%
34. Wounds and Injuries 12%
35. Serum 12%
36. Lung Neoplasms 12%
37. Schizophrenia 11%
38. In Vitro Techniques 11%
39. Inflammation 11%
40. Calcium 11%
41. Autophagy 11%
42. Growth 11%
43. National Health Programs 11%
44. MicroRNAs 11%
45. Gene Expression 10%
46. Neoplastic Stem Cells 10%
47. Survival 10%
48. Chronic Obstructive Pulmonary Disease 10%
49. Up-Regulation 10%
50. Carcinoma 10%
51. Catenins 10%
52. Methylation 9%
53. Drug Therapy 9%
54. Endothelial Cells 9%
55. Oxidative Stress 9%
56. Non-Small Cell Lung Carcinoma 9%
57. Prostatic Neoplasms 9%
58. Epithelial-Mesenchymal Transition 9%
59. Mesenchymal Stem Cells 9%
60. Heme Oxygenase-1 9%
61. Lipopolysaccharides 9%
62. Hyperoxia 9%
63. Cell Line 9%
64. Macrophages 8%
65. Cell Movement 8%
66. Peroxisome Proliferator-Activated Receptors 8%
67. Nitric Oxide 8%
68. Retrospective Studies 8%
69. ErbB Receptors 8%
70. Metabolic Syndrome 8%
71. Fibrosis 8%
72. Sleep 8%
73. Dialysis 8%
74. Case-Control Studies 8%
75. Mouth Neoplasms 8%
76. Cell Proliferation 8%
77. Hypertension 8%
78. Recurrence 8%
79. Colonic Neoplasms 8%
80. Glioblastoma 7%
81. Pharmaceutical Preparations 7%
82. Ovarian Neoplasms 7%
83. Blood Pressure 7%
84. Safety 7%
85. Chronic Kidney Failure 7%
86. Diabetes Mellitus 7%
87. Fibroblasts 7%
88. Pneumonia 7%
89. Liver 7%
90. Messenger RNA 7%
91. Quality of Life 7%
92. Bone and Bones 7%
93. Mutation 7%
94. Triple Negative Breast Neoplasms 7%
95. Skin 7%
96. Dementia 7%
97. Angiotensin II 7%
98. Logistic Models 7%
99. Brain 7%
100. Antioxidants 7%